Actionable news
All posts from Actionable news

Perilous Reversal Watch: Ionis Pharmaceuticals (IONS)

Trade-Ideas LLC identified Ionis Pharmaceuticals ( IONS) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Ionis Pharmaceuticals as such a stock due to the following factors:

  • IONS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $98.0 million.
  • IONS has traded 145,210 shares today.
  • IONS is down 9.7% today.
  • IONS was up 9.3% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in IONS with the Ticky from Trade-Ideas. See the FREE profile for IONS NOW at Trade-Ideas More details on IONS: Ionis Pharmaceuticals, Inc., a RNA-targeted drug discovery and development company, develops drugs for patients with severe and rare diseases in the United States. Currently there are 4 analysts that rate Ionis Pharmaceuticals a buy, 1 analyst rates it a sell, and 3 rate it a hold. The average volume for Ionis Pharmaceuticals has been 2.1 million shares per day over the past 30 days. Ionis has a market cap of $4.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.15 and a short float of 10.4% with 4.51 days to cover. Shares are down 33.8% year-to-date...